Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis

Because of the pathological role of IL-6 in rheumatoid arthritis (RA), tocilizumab (TCZ), a humanized anti-IL-6 receptor monoclonal antibody, was expected to improve inflammation and joint destruction of RA. Indeed, randomized clinical trials demonstrated the clinical efficacy of TCZ as monotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Atsushi, Hirano, Toru, Hishitani, Yoshihiro, Tanaka, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2012
Materias:
Expert Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306224/
https://www.ncbi.nlm.nih.gov/pubmed/22438671
http://dx.doi.org/10.4137/CMAMD.S7371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306224/
https://www.ncbi.nlm.nih.gov/pubmed/22438671
http://dx.doi.org/10.4137/CMAMD.S7371

Ejemplares similares